Verition Fund Management
ELAN icon

Verition Fund Management’s Elanco Animal Health ELAN Stock Holding History

Verition Fund Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15M Buy
250,000
+38,713
+18% +$895K 0.03% 566
2026
Q1 		$5.06M Sell
211,287
-112,662
-35% -$2.75M 0.03% 576
2025
Q4 		$7.33M Buy
323,949
+305,734
+1,678% +$6.65M 0.03% 621
2025
Q3 		$367K Sell
18,215
-19,934
-52% -$334K ﹤0.01% 3198
2025
Q2 		$545K Sell
38,149
-8,307
-18% -$97.1K ﹤0.01% 2884
2025
Q1 		$488K Buy
46,456
+10,961
+31% +$124K ﹤0.01% 2603
2024
Q4 		$430K Buy
35,495
+21,322
+150% +$279K ﹤0.01% 2568
2024
Q3 		$208K Sell
14,173
-19,820
-58% -$276K ﹤0.01% 2867
2024
Q2 		$491K Buy
33,993
+21,004
+162% +$336K ﹤0.01% 2061
2024
Q1 		$211K Sell
12,989
-11,474
-47% -$179K ﹤0.01% 2472
2023
Q4 		$364K Buy
24,463
+11,850
+94% +$134K ﹤0.01% 1682
2023
Q3 		$142K Sell
12,613
-124,412
-91% -$1.44M ﹤0.01% 2064
2023
Q2 		$1.38M Buy
137,025
+95,312
+228% +$885K 0.02% 826
2023
Q1 		$392K Sell
41,713
-6,379
-13% -$75.3K 0.01% 1379
2022
Q4 		$588K Sell
48,092
-75,566
-61% -$942K 0.01% 1162
2022
Q3 		$1.53M Buy
123,658
+32,031
+35% +$560K 0.02% 1092
2022
Q2 		$1.8M Buy
91,627
+72,208
+372% +$1.71M 0.04% 721
2022
Q1 		$507K Sell
19,419
-9,192
-32% -$245K 0.01% 1891
2021
Q4 		$812K Buy
+28,611
New +$890K 0.01% 1424
2021
Q3 		– Sell
-8,745
Closed -$303K – 2003
2021
Q2 		$303K Buy
8,745
+1,350
+18% +$44.5K ﹤0.01% 1337
2021
Q1 		$218K Sell
7,395
-45,474
-86% -$1.4M ﹤0.01% 1291
2020
Q4 		$1.62M Buy
+52,869
New +$1.61M 0.01% 418
2020
Q2 		– Sell
-128,709
Closed -$2.88M – 1077
2020
Q1 		$2.88M Buy
+128,709
New +$3.53M 0.11% 124
2019
Q4 		– Sell
-10,908
Closed -$290K – 1149
2019
Q3 		$290K Buy
10,908
+4,675
+75% +$140K 0.01% 817
2019
Q2 		$211K Sell
6,233
-21,464
-77% -$697K 0.01% 966
2019
Q1 		$888K Buy
+27,697
New +$852K 0.03% 441

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Verition Fund Management's ELAN Position: Q2 2026 in Review

Verition Fund Management increased its Elanco Animal Health (ELAN) stake by 18% in Q2 2026, buying an estimated $895K and bringing the position to 250,000 shares worth $6.15M. The position accounts for 0.03% of the portfolio, ranked #566.

Verition Fund Management first reported a position in ELAN in Q1 2019 and has held it in 26 quarters since. The position peaked at $7.33M in Q4 2025. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Verition Fund Management held 250,000 shares of Elanco Animal Health worth $6.15M as of Q2 2026.
  • Verition Fund Management bought 38,713 Elanco Animal Health shares in Q2 2026, an estimated $895K.
  • Elanco Animal Health made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #566 holding.
  • Verition Fund Management first reported a position in Elanco Animal Health in Q1 2019 and has held it in 26 quarters since.
  • Verition Fund Management's Elanco Animal Health position peaked at $7.33M in Q4 2025.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.